Simmons Cancer Institute at SIU Banner
Link: Patient Care
Link: Clinical Trials
Link: Cancer Information
Link: About Us
Link: How to Help
Quick Links below
Link: New Patients
Link: Patient Navigator
Link: Side by Side Program
Link: Support Groups
Link: Maps and Locations
Link: Cancer Wellness
Link: Outreach Program
Physycians and Health Care Professionals links below
Link: Web-based CME Programs
Link: Membership
Link: Research
Link: Grant and Funding
Link: SCCI Home Page
Link: Prevention Tips and Screenings
Link: News


Sarcoma Studies Currently Recruiting Participants at the Simmons Cancer Research Center at Southern Illinois University School of Medicine

Protocol Title Study # Study Group
A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma COG AEWS1031 SIU COG
A Phase I/II Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma 08-078 SCI
A Phase 2 Study of Temsirolimus (CCI-779, NSC 683864) and IGF-1 Receptor Antibody IMC-A12 (NSC 742460) in Patients with Metastatic Sarcomas. 10-047 SCI
Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy COG     ARST0331 SIU COG
Risk-Based Treatment for Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) COG     ARST0332 SIU COG
A Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS) COG   ARST0531 SIU COG
EURO-E.W.I.N.G. 99 - European Ewing Tumour Working Initiative of National Groups - Ewing Tumour Studies 1999 - EE 99 COG AEWS0331 SIU COG
A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy - A Phase III Intergroup Study COG  AOST0331 SIU COG

Although our objective is to provide an updated listing of available clinical trials please note that a listing here does not guarantee that a trial is open or available to any specific patient and that there may be additional trials available that are not listed. Complete information is only available from a treating physician.


Contact Information:

Simmons Cancer Institute Clinical Trials Office
Mail Code 9677          Fax (217) 545-6823

Kathy Robinson, PhD,
Director of Clinical Trials
(217) 545-1946
 

Allicent Curry, RN,BSN, OCN
Research Nurse
(217) 545-7929
 
 
 
 
 

SIU Behavioral & Psychosocial Oncology

Anna Wiggins, MS, LCPC
(217) 545-5408
 

SIU COG

Carol Peterson, RN, CCRP (217) 545-7377

SIU IM

Amanda Fogleman, B.S. (217) 545-0592
Krista Whitlock (217) 545-7750

SIU Thoracic

Theresa Boley, RN, MSN, APN/FNP-BC, CCRP (217) 545-5000
 
Cathy Leslie, RN, CCRP (217) 545-8184
Mary Ray, MS (217) 545-7420
 

RTOG:  Radiation Therapy Oncology Group:

Diana Weyhenmeyer, RN, MA, OCN  (217) 544-6464 ext. 45591

CICCOP:  Central Illinois Community Clinical Oncology Program
Memorial Medical Center CICCOP Research Contacts:

Treatment/Cancer Control:

Holly Thomas (217) 788-4178
Stephanie Allbritton (217) 788-3544
Brooke Trickey (217) 217-788-3560
Karen Graber (217) 588-2961
Chrissy Tucker (217) 788-4444
Sunny Hampsey (217) 788-4233

Back to Open Clinical Trials

Home / Patient Care / Clinical Trials / Cancer Information / How to Help / About Us
SIU-SM Home / About SIU-SM / Directories / News/Info / SIU Carbondale / Search / Privacy Policy
Copyright © 2010 Board of Trustees, Southern Illinois University
Contact the webmaster........ Last Updated 04/16/10........